Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 69 citing articles:

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
Holger Moch, Mahul B. Amin, Daniel M. Berney, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 458-468
Open Access | Times Cited: 442
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
Kiril Trpkov, Sean R. Williamson, Anthony J. Gill, et al.
Modern Pathology (2021) Vol. 34, Iss. 6, pp. 1167-1184
Open Access | Times Cited: 175
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217
Naoto Kuroda, Kiril Trpkov, Yuan Gao, et al.
Modern Pathology (2020) Vol. 33, Iss. 12, pp. 2564-2579
Open Access | Times Cited: 79
What’s new in the WHO 2022 classification of kidney tumours?
Reza Alaghehbandan, Farshid Siadat, Kiril Trpkov
Pathologica (2023), pp. 1-15
Open Access | Times Cited: 34
The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates
Parth Goswami, Gyanendra Singh, Tarang Patel, et al.
Cureus (2024)
Open Access | Times Cited: 8
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases
Mihaela Farcaş, Zoran Gatalica, Kiril Trpkov, et al.
Modern Pathology (2021) Vol. 35, Iss. 3, pp. 344-351
Open Access | Times Cited: 55
Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney
Payal Kapur, Ming Gao, Hua Zhong, et al.
Modern Pathology (2021) Vol. 35, Iss. 3, pp. 333-343
Open Access | Times Cited: 47
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1
Aurélien Morini, Tom Drossart, M.-O. Timsit, et al.
Modern Pathology (2021) Vol. 35, Iss. 3, pp. 352-360
Open Access | Times Cited: 43
Renal Cell Carcinoma in Tuberous Sclerosis Complex
Elizabeth P. Henske, Kristine M. Cornejo, Chin‐Lee Wu
Genes (2021) Vol. 12, Iss. 10, pp. 1585-1585
Open Access | Times Cited: 42
French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
Pierre Bigot, Philippe Barthélémy, R. Boissier, et al.
Progrès en Urologie (2022) Vol. 32, Iss. 15, pp. 1195-1274
Closed Access | Times Cited: 33
Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity
Sean R. Williamson, Ondřej Hes, Kiril Trpkov, et al.
Histopathology (2022) Vol. 82, Iss. 2, pp. 296-304
Closed Access | Times Cited: 32
Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China
Qianru Guo, Ning Liu, Frank Wang, et al.
Virchows Archiv (2020) Vol. 478, Iss. 3, pp. 449-458
Closed Access | Times Cited: 41
Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute
Mahmut Akgul, Khaleel I. Al‐Obaidy, Liang Cheng, et al.
Journal of Clinical Pathology (2021) Vol. 75, Iss. 11, pp. 772-775
Closed Access | Times Cited: 39
Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex
Luisa Angelica Lerma, George R. Schade, Maria Tretiakova
Human Pathology (2021) Vol. 116, pp. 1-11
Closed Access | Times Cited: 39
Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss
Payal Kapur, Ming Gao, Hua Zhong, et al.
Advances in Anatomic Pathology (2021) Vol. 28, Iss. 4, pp. 251-257
Open Access | Times Cited: 34
Papillary renal cell carcinoma: current and controversial issues
Silvia Angori, João Lobo, Holger Moch
Current Opinion in Urology (2022) Vol. 32, Iss. 4, pp. 344-351
Open Access | Times Cited: 28
Do we need an updated classification of oncocytic renal tumors?
Ondřej Hes, Kiril Trpkov
Modern Pathology (2022) Vol. 35, Iss. 9, pp. 1140-1150
Open Access | Times Cited: 27
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 24
Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting
Payal Kapur, James Brugarolas, Kiril Trpkov
Cancers (2023) Vol. 15, Iss. 16, pp. 4043-4043
Open Access | Times Cited: 14
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors
Anna Caliò, Matteo Brunelli, Stefano Gobbo, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2441-2441
Open Access | Times Cited: 32
Classification of renal cell tumors – current concepts and use of ancillary tests: recommendations of the Brazilian Society of Pathology
Daniel Abensur Athanazio, Luciana Schultz, Isabela Werneck da Cunha, et al.
Surgical and Experimental Pathology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 32
TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background
Kristýna Pivovarčíková, Reza Alaghehbandan, Tomáš Vaněček, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 322-322
Open Access | Times Cited: 19
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer
Francesco Trevisani, Matteo Floris, Roberto Minnei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2603-2603
Open Access | Times Cited: 19
Renal Cell Carcinoma with ALK-TPM3 Gene Fusion and ALK Amplification：A Case Report and literature review
Xinzhuo Tu, Min Zhu, Qingyue Liu, et al.
Pathology - Research and Practice (2025) Vol. 266, pp. 155814-155814
Closed Access
High-grade eosinophilic renal tumor/eosinophilic vacuolar renal tumor: a case report and literature review
Yong Ou, Shangqing Ren, Fang Zhou, et al.
BMC Urology (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top